LP Attorney Cameron Stephenson Appointed to Plaintiffs’ Executive Committee in GLP-1 Vision Loss MDL February 24, 2026 On February 23, 2026, the United States District Court for the Eastern District of Pennsylvania appointed Cameron Stephenson, a shareholder at Levin Papantonio, to the Plaintiffs’ Executive Committee in the consolidated federal litigation involving glucagon-like peptide-1 (GLP-1) receptor agonist drugs and alleged non-arteritic anterior ischemic optic neuropathy (NAION). In a case management order, Judge Karen […] Read More
Dupixent Lawsuits Sought to Be Centralized in Georgia February 23, 2026 Plaintiffs in 15 federal lawsuits involving the prescription drug Dupixent (dupilumab) have asked the Judicial Panel on Multidistrict Litigation (“JPML”) to transfer and consolidate all related cases, spread amongst 9 federal districts, to one federal court. Plaintiffs’ lawsuits allege that, as a result of using Dupixent, they developed cutaneous T-cell lymphoma (CTCL). In February 2026, […] Read More
Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio January 9, 2026 At a Case Management Conference in the multidistrict litigation (MDL) against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first trial, which will take place in December 2026, as more than 2,100 women pursue litigation alleging Pfizer failed to adequately warn patients despite long-standing knowledge of the risk. The hearing […] Read More
Levin Law
Levin Law